◀ Back to BCL9

BCL9 — EPO

Text-mined interactions from Literome

Sola et al., Pediatr Res 2005 (Brain Ischemia...) : The most effective dose after FCI was 1000 U/kg for 3 d. Immunoanalyses showed that Epo induced a significant increase in phosphorylated Janus kinase 2 and signal transducer and activator of transcription-5 expressions at 1 and 3 d and up-regulated Bcl-xL expression by 24 h after FCI but did not affect Epo receptor or NF-kappaB expression
Diwan et al., Apoptosis 2008 (Anemia...) : Previously, we found that BH3-only proapoptotic factor, Nix, opposed erythroblast-survival signaling by erythropoietin induced Bcl-xl during normal erythrocyte formation
Okazaki et al., Neoplasia (New York, N.Y.) 2008 (Neovascularization, Pathologic) : Erythropoietin activated the extracellular signal regulated kinase signaling pathway and up-regulated the expression of the downstream antiapoptotic protein Bcl-xL in HMVECs